Go back

Qdossier Qsauri
"R"

reference listed drug
Guideline or reference source
FDA www.fda.gov
Definition
An approved drug product to which new generic versions are compared to show that they are bioequivalent. A drug company seeking approval to market a generic equivalent must refer to the Reference Listed Drug in its Abbreviated New Drug Application (ANDA). By designating a single reference listed drug as the standard to which all generic versions must be shown to be bioequivalent, FDA hopes to avoid possible significant variations among generic drugs and their brand name counterpart.
Abbreviation for
RLD
Related Term
abbreviated new drug application
bioequivalence
generic medicinal product
 

Send comments to info@qdossier.com Please read disclaimer before using Qsauri.